South Korea-based GC Cell, a leader in the cell and gene therapy (CGT) sector within the biopharmaceutical industry, and ...

Andelyn Biosciences and PQP Group have partnered to streamline cell and gene therapy supply to the EU and UK, integrating ...

GE HealthCare buys SOFIE Biosciences for $945 M to establish 'Final Mile' footprint for PET Radiopharmaceutical Supply in US ...

Charles River and Autolomous launch Apollo Orchestrate to digitize GMP laboratory execution and connect biologics testing workflows in North America and Europe.

If the opening day of BioJapan 2026 diagnosed the gap between Japanese science and global deals, the second day at PACIFICO ...

China-based startup Abogen Biosciences, a clinical-stage biotechnology group pioneering RNA innovation, has entered into a ...

Docquity, the Singapore-based clinical AI platform for more than 75% of verified doctors across Asia, has announced its scale ...

BioJapan 2026, Regenerative Medicine JAPAN and healthTECH JAPAN, PACIFICO Yokohama, 7 to 9 October Forty years after its first edition in 1986, BioJapan opened its 2026 edition at PACIFICO Yokohama on ...

AstraZeneca has announced the opening of its newest global strategic research and development (R&D) centre, in Kendall Square, Cambridge, Massachusetts, US.

As BioSpectrum Asia marks its 20th year, this year's awards honour the industry stalwarts redefining Asian life sciences, from bioprocessing and AI drug discovery to advanced diagnostics, cell therapy ...

NUS launches S$50M National Centre for Engineering Biology to accelerate AI-guided sustainable biomanufacturing ...

Australia's CSL inks $1.2 B deal with Swiss firm Alentis to develop lixudebart for rare kidney and liver diseases treatment ...